Figures & data
Figure 1 Deregulated alterations of fatty acid and cholesterol metabolism in hepatocellular carcinoma. The glycolysis pathway: GLUTs, glucose transporters; PDH, pyruvate dehydrogenase. Cholesterol metabolism: HMG-CoA, 3-hydroxy-3-methylglutaryl coenzymeA; LDL, low density lipoprotein.
![Figure 1 Deregulated alterations of fatty acid and cholesterol metabolism in hepatocellular carcinoma. The glycolysis pathway: GLUTs, glucose transporters; PDH, pyruvate dehydrogenase. Cholesterol metabolism: HMG-CoA, 3-hydroxy-3-methylglutaryl coenzymeA; LDL, low density lipoprotein.](/cms/asset/81cae1a5-efea-486c-82a2-33ad182a1a59/djhc_a_12299712_f0001_c.jpg)
Table 1 The Impact of Therapeutic Drugs Targeting the Lipid Metabolism Pathway on the Treatment of Hepatocellular Carcinoma